279 related articles for article (PubMed ID: 6814784)
1. Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.
Ross DL; Sze DY; Keefe DL; Swerdlow CD; Echt DS; Griffin JC; Winkle RA; Mason JW
Circulation; 1982 Dec; 66(6):1205-10. PubMed ID: 6814784
[TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmic drug therapy for sustained ventricular tachycardia.
Kienzle MG; Williams PD; Zygmont D; Doherty JU; Josephson ME
Heart Lung; 1984 Nov; 13(6):614-22. PubMed ID: 6149202
[TBL] [Abstract][Full Text] [Related]
3. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
Nestico PF; Morganroth J
Cardiol Clin; 1986 May; 4(2):285-303. PubMed ID: 3085932
[TBL] [Abstract][Full Text] [Related]
4. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
Horowitz LN; Josephson ME; Farshidi A; Spielman SR; Michelson EL; Greenspan AM
Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic agents for chronic ventricular arrhythmias.
Nestico PF; Morganroth J
Compr Ther; 1987 Apr; 13(4):26-35. PubMed ID: 3105950
[TBL] [Abstract][Full Text] [Related]
6. Antiarrhythmic drugs.
Roy D
Can Anaesth Soc J; 1986 May; 33(3 Pt 2):S65-7. PubMed ID: 2872953
[No Abstract] [Full Text] [Related]
7. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.
Waxman HL; Buxton AE; Sadowski LM; Josephson ME
Circulation; 1983 Jan; 67(1):30-7. PubMed ID: 6847803
[TBL] [Abstract][Full Text] [Related]
8. New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.
Kreeger RW; Hammill SC
Mayo Clin Proc; 1987 Nov; 62(11):1033-50. PubMed ID: 3118116
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease.
Reiter MJ; Easley AR; Mann DE
Am J Cardiol; 1987 Jun; 59(15):1319-24. PubMed ID: 3109228
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of combination of IB and IC antiarrhythmics for the treatment of ventricular tachycardia.
Bleske BE; Kluger J; Fisher J; Chow MS
J Clin Pharmacol; 1989 Nov; 29(11):998-1002. PubMed ID: 2513339
[TBL] [Abstract][Full Text] [Related]
11. A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia.
Toivonen L; Kadish A; Morady F
Circulation; 1991 Jul; 84(1):101-8. PubMed ID: 1905591
[TBL] [Abstract][Full Text] [Related]
12. [Interactions of quinidine and propranolol with mexiletine, encainide, flecainide and tocainide].
Halawa B
Pol Tyg Lek; 1990 Mar 5-12; 45(10-11):222-4. PubMed ID: 2120685
[TBL] [Abstract][Full Text] [Related]
13. New directions in antiarrhythmic drug therapy.
Somberg JC
Am J Cardiol; 1984 Aug; 54(4):8B-17B. PubMed ID: 6147082
[TBL] [Abstract][Full Text] [Related]
14. Comparative hemodynamic effects of procainamide, tocainide, and encainide in severe chronic heart failure.
Gottlieb SS; Kukin ML; Medina N; Yushak M; Packer M
Circulation; 1990 Mar; 81(3):860-4. PubMed ID: 2106401
[TBL] [Abstract][Full Text] [Related]
15. Metabolites of antiarrhythmic drugs: are they clinically important?
Kates RE
Ration Drug Ther; 1986 May; 20(5):1-5. PubMed ID: 3097754
[No Abstract] [Full Text] [Related]
16. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
Roden DM; Lee JT; Woosley RL; Echt DS
Circulation; 1989 Nov; 80(5):1247-58. PubMed ID: 2805262
[TBL] [Abstract][Full Text] [Related]
17. Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.
Mason JW; Winkle RA
Circulation; 1978 Dec; 58(6):971-85. PubMed ID: 709781
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic efficacy of encainide and quinidine: validation of a model for drug assessment.
Sami M; Harrison DC; Kraemer H; Houston N; Shimasaki C; DeBusk RF
Am J Cardiol; 1981 Jul; 48(1):147-56. PubMed ID: 6787910
[No Abstract] [Full Text] [Related]
19. Reliability of antiarrhythmic drug plasma concentration monitoring.
Follath F; Ganzinger U; Schuetz E
Clin Pharmacokinet; 1983; 8(1):63-82. PubMed ID: 6404580
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacology of old and new antiarrhythmic drugs.
Siddoway LA; Roden DM; Woosley RL
Cardiovasc Clin; 1985; 15(3):199-248. PubMed ID: 2870805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
